Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1985 2
1986 2
1987 2
1989 4
1990 1
1991 2
1992 2
1994 6
1995 2
1996 7
1997 5
1998 6
1999 6
2000 13
2001 20
2002 22
2003 30
2004 41
2005 44
2006 53
2007 59
2008 65
2009 85
2010 112
2011 134
2012 130
2013 157
2014 183
2015 215
2016 240
2017 251
2018 278
2019 333
2020 439
2021 470
2022 272
Text availability
Article attribute
Article type
Publication date

Search Results

3,295 results
Results by year
Filters applied: . Clear all
Page 1
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.
Cao Y, Yisimayi A, Bai Y, Huang W, Li X, Zhang Z, Yuan T, An R, Wang J, Xiao T, Du S, Ma W, Song L, Li Y, Li X, Song W, Wu J, Liu S, Li X, Zhang Y, Su B, Guo X, Wei Y, Gao C, Zhang N, Zhang Y, Dou Y, Xu X, Shi R, Lu B, Jin R, Ma Y, Qin C, Wang Y, Feng Y, Xiao J, Xie XS. Cao Y, et al. Among authors: shi r. Cell Res. 2021 Jul;31(7):732-741. doi: 10.1038/s41422-021-00514-9. Epub 2021 May 21. Cell Res. 2021. PMID: 34021265 Free PMC article.
Stroke subtype-dependent synapse elimination by reactive gliosis in mice.
Shi X, Luo L, Wang J, Shen H, Li Y, Mamtilahun M, Liu C, Shi R, Lee JH, Tian H, Zhang Z, Wang Y, Chung WS, Tang Y, Yang GY. Shi X, et al. Among authors: shi r. Nat Commun. 2021 Nov 26;12(1):6943. doi: 10.1038/s41467-021-27248-x. Nat Commun. 2021. PMID: 34836962 Free PMC article.
Collagen prolyl 4-hydroxylases modify tumor progression.
Shi R, Gao S, Zhang J, Xu J, Graham LM, Yang X, Li C. Shi R, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Jul 5;53(7):805-814. doi: 10.1093/abbs/gmab065. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 34009234 Free PMC article. Review.
SS18 regulates pluripotent-somatic transition through phase separation.
Kuang J, Zhai Z, Li P, Shi R, Guo W, Yao Y, Guo J, Zhao G, He J, Xu S, Wu C, Yu S, Zhou C, Wu L, Qin Y, Cai B, Li W, Wu Z, Li X, Chu S, Yang T, Wang B, Cao S, Li D, Zhang X, Chen J, Liu J, Pei D. Kuang J, et al. Among authors: shi r. Nat Commun. 2021 Jul 2;12(1):4090. doi: 10.1038/s41467-021-24373-5. Nat Commun. 2021. PMID: 34215745 Free PMC article.
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants.
Du Y, Shi R, Zhang Y, Duan X, Li L, Zhang J, Wang F, Zhang R, Shen H, Wang Y, Wu Z, Peng Q, Pan T, Sun W, Huang W, Feng Y, Feng H, Xiao J, Tan W, Wang Y, Wang C, Yan J. Du Y, et al. Among authors: shi r. Nat Commun. 2021 Aug 17;12(1):5000. doi: 10.1038/s41467-021-25331-x. Nat Commun. 2021. PMID: 34404805 Free PMC article.
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.
Hasni SA, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Carlucci PM, Wang X, Naqi M, Playford MP, Goel RR, Li X, Biehl AJ, Ochoa-Navas I, Manna Z, Shi Y, Thomas D, Chen J, Biancotto A, Apps R, Cheung F, Kotliarov Y, Babyak AL, Zhou H, Shi R, Stagliano K, Tsai WL, Vian L, Gazaniga N, Giudice V, Lu S, Brooks SR, MacKay M, Gregersen P, Mehta NN, Remaley AT, Diamond B, O'Shea JJ, Gadina M, Kaplan MJ. Hasni SA, et al. Among authors: shi r. Nat Commun. 2021 Jun 7;12(1):3391. doi: 10.1038/s41467-021-23361-z. Nat Commun. 2021. PMID: 34099646 Free PMC article. Clinical Trial.
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.
Jänne PA, Baik C, Su WC, Johnson ML, Hayashi H, Nishio M, Kim DW, Koczywas M, Gold KA, Steuer CE, Murakami H, Yang JC, Kim SW, Vigliotti M, Shi R, Qi Z, Qiu Y, Zhao L, Sternberg D, Yu C, Yu HA. Jänne PA, et al. Among authors: shi r. Cancer Discov. 2022 Jan;12(1):74-89. doi: 10.1158/2159-8290.CD-21-0715. Epub 2021 Sep 21. Cancer Discov. 2022. PMID: 34548309 Clinical Trial.
3,295 results